234 related articles for article (PubMed ID: 18035962)
21. Basic, translational and clinical aspects of bronchiectasis in adults.
Chalmers JD; Elborn S; Greene CM
Eur Respir Rev; 2023 Jun; 32(168):. PubMed ID: 37286220
[TBL] [Abstract][Full Text] [Related]
22. Respiratory infection in noncystic fibrosis bronchiectasis.
Zoumot Z; Wilson R
Curr Opin Infect Dis; 2010 Apr; 23(2):165-70. PubMed ID: 19996746
[TBL] [Abstract][Full Text] [Related]
23. Raising awareness of bronchiectasis in primary care: overview of diagnosis and management strategies in adults.
Chalmers JD; Sethi S
NPJ Prim Care Respir Med; 2017 Mar; 27(1):18. PubMed ID: 28270656
[TBL] [Abstract][Full Text] [Related]
24. Use of aerosols in bronchiectasis patients.
Dal Negro RW; Micheletto C; Tognella S
Monaldi Arch Chest Dis; 2011 Sep; 75(3):185-93. PubMed ID: 22428222
[TBL] [Abstract][Full Text] [Related]
25. Management of Non-Cystic Fibrosis Bronchiectasis.
Dull SK; Havlat BD; Sanley MJ; Malesker MA
Consult Pharm; 2018 Nov; 33(11):658-666. PubMed ID: 30458908
[No Abstract] [Full Text] [Related]
26. [Diagnosis and treatment of bronchiectasis. Spanish Society of Pneumology and Thoracic Surgery].
Vendrell M; de Gracia J; Olveira C; Martinez-Garcia MA; Girón R; Máiz L; Cantón R; Coll R; Escribano A; Solé A
Arch Bronconeumol; 2008 Nov; 44(11):629-40. PubMed ID: 19007570
[TBL] [Abstract][Full Text] [Related]
27. Bronchiectasis management in adults: state of the art and future directions.
Choi H; McShane PJ; Aliberti S; Chalmers JD
Eur Respir J; 2024 Jun; 63(6):. PubMed ID: 38782469
[TBL] [Abstract][Full Text] [Related]
28. [Pathophysiology and treatment of bronchectasis].
Turcanu AM; Mihăescu T
Pneumologia; 2011; 60(1):26-9. PubMed ID: 21548197
[TBL] [Abstract][Full Text] [Related]
29. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
[TBL] [Abstract][Full Text] [Related]
30. Challenges in the development of new therapies for bronchiectasis.
Chalmers JD; Loebinger M; Aliberti S
Expert Opin Pharmacother; 2015 Apr; 16(6):833-50. PubMed ID: 25800083
[TBL] [Abstract][Full Text] [Related]
31. [Inhaled antibiotics in the treatment of noncystic fibrosis bronchiectasis].
Martínez García MÁ; Soler Cataluña JJ; Serra PC
Arch Bronconeumol; 2011 Jun; 47 Suppl 6():19-23. PubMed ID: 21703475
[TBL] [Abstract][Full Text] [Related]
32. Bronchiectasis, Chronic Suppurative Lung Disease and Protracted Bacterial Bronchitis.
Benscoter DT
Curr Probl Pediatr Adolesc Health Care; 2018 Apr; 48(4):119-123. PubMed ID: 29602647
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial treatment of non-cystic fibrosis bronchiectasis.
Grimwood K; Bell SC; Chang AB
Expert Rev Anti Infect Ther; 2014 Oct; 12(10):1277-96. PubMed ID: 25156239
[TBL] [Abstract][Full Text] [Related]
34. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis.
Tsang KW; Ho PL; Lam WK; Ip MS; Chan KN; Ho CS; Ooi CC; Yuen KY
Am J Respir Crit Care Med; 1998 Sep; 158(3):723-7. PubMed ID: 9730996
[TBL] [Abstract][Full Text] [Related]
35. European Respiratory Society guidelines for the management of adult bronchiectasis.
Polverino E; Goeminne PC; McDonnell MJ; Aliberti S; Marshall SE; Loebinger MR; Murris M; Cantón R; Torres A; Dimakou K; De Soyza A; Hill AT; Haworth CS; Vendrell M; Ringshausen FC; Subotic D; Wilson R; Vilaró J; Stallberg B; Welte T; Rohde G; Blasi F; Elborn S; Almagro M; Timothy A; Ruddy T; Tonia T; Rigau D; Chalmers JD
Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28889110
[TBL] [Abstract][Full Text] [Related]
36. A Chronic Respiratory Pasteurella multocida Infection Is Well-Controlled by Long-Term Macrolide Therapy.
Seki M; Sakata T; Toyokawa M; Nishi I; Tomono K
Intern Med; 2016; 55(3):307-10. PubMed ID: 26831030
[TBL] [Abstract][Full Text] [Related]
37. The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis.
Dhand R
J Aerosol Med Pulm Drug Deliv; 2018 Jun; 31(3):121-138. PubMed ID: 29077527
[TBL] [Abstract][Full Text] [Related]
38. Using Cystic Fibrosis Therapies for Non-Cystic Fibrosis Bronchiectasis.
ElMaraachli W; Conrad DJ; Wang AC
Clin Chest Med; 2016 Mar; 37(1):139-46. PubMed ID: 26857775
[TBL] [Abstract][Full Text] [Related]
39. Non-cystic fibrosis bronchiectasis.
McShane PJ; Naureckas ET; Tino G; Strek ME
Am J Respir Crit Care Med; 2013 Sep; 188(6):647-56. PubMed ID: 23898922
[TBL] [Abstract][Full Text] [Related]
40. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.
Bilton D; Tino G; Barker AF; Chambers DC; De Soyza A; Dupont LJ; O'Dochartaigh C; van Haren EH; Vidal LO; Welte T; Fox HG; Wu J; Charlton B;
Thorax; 2014 Dec; 69(12):1073-9. PubMed ID: 25246664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
